Friedrich E. Kruse

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 276 publications

Targeting RhoA/ROCK Signaling to Modulate Extracellular Matrix Remodeling in Corneal Endothelial Dystrophies.

Targeting RhoA/ROCK Signaling to Modulate Extracellular Matrix Remodeling in Corneal Endothelial Dystrophies.

Journal: Investigative ophthalmology & visual science

Published: August 13, 2026

Refining How We Diagnose and Classify Limbal Stem Cell deficiency.

Refining How We Diagnose and Classify Limbal Stem Cell deficiency.

Journal: American journal of ophthalmology

Published: July 11, 2026

Protective Effects of Estradiol on Disease Progression in a Murine Model of Fuchs Endothelial Corneal Dystrophy.

Protective Effects of Estradiol on Disease Progression in a Murine Model of Fuchs Endothelial Corneal Dystrophy.

Journal: Investigative ophthalmology & visual science

Published: January 14, 2026

Structure-based virtual screening identifies VX-809 as a candidate dual-pathway modulator in fuchs endothelial corneal dystrophy.

Structure-based virtual screening identifies VX-809 as a candidate dual-pathway modulator in fuchs endothelial corneal dystrophy.

Journal: Scientific reports

Published: January 10, 2026

Perimetry of the Central Visual Field Using a Head-Mounted Open-Source Perimeter in Patients with Inherited Retinal Diseases.

Perimetry of the Central Visual Field Using a Head-Mounted Open-Source Perimeter in Patients with Inherited Retinal Diseases.

Journal: Vision (Basel, Switzerland)

Published: January 07, 2026

Descemet Stripping Only in Fuchs Endothelial Corneal Dystrophy: Results of a Randomized Clinical Trial of Topical Ripasudil and Directions for Future Innovation.

Descemet Stripping Only in Fuchs Endothelial Corneal Dystrophy: Results of a Randomized Clinical Trial of Topical Ripasudil and Directions for Future Innovation.

Journal: American journal of ophthalmology

Published: December 22, 2025

Scrolling Behavior of Descemet Membrane Endothelial Keratoplasty Grafts: Analysis of a Large Cohort of 3150 Grafts.

Scrolling Behavior of Descemet Membrane Endothelial Keratoplasty Grafts: Analysis of a Large Cohort of 3150 Grafts.

Journal: Cornea

Published: October 24, 2025

Establishment of an Advanced In Vitro Model for Pseudoexfoliation Syndrome and Glaucoma.

Establishment of an Advanced In Vitro Model for Pseudoexfoliation Syndrome and Glaucoma.

Journal: Investigative ophthalmology & visual science

Published: September 25, 2025

The PERK-p38 MAPK Axis Drives Endoplasmic Reticulum Stress-Induced Apoptosis in Fuchs Endothelial Corneal Dystrophy.

The PERK-p38 MAPK Axis Drives Endoplasmic Reticulum Stress-Induced Apoptosis in Fuchs Endothelial Corneal Dystrophy.

Journal: Investigative ophthalmology & visual science

Published: August 26, 2025

Secondary Graft Failure After Descemet Membrane Endothelial Keratoplasty: Clinical Characteristics and Ultrastructural Findings of Failed Grafts.

Secondary Graft Failure After Descemet Membrane Endothelial Keratoplasty: Clinical Characteristics and Ultrastructural Findings of Failed Grafts.

Journal: Cornea

Published: August 12, 2025

Dysregulation of Transient Receptor Potential Cation Channels and Epithelial-to-Mesenchymal Transition-Related Genes in Fuchs Endothelial Corneal Dystrophy: A Bioinformatics Approach.

Dysregulation of Transient Receptor Potential Cation Channels and Epithelial-to-Mesenchymal Transition-Related Genes in Fuchs Endothelial Corneal Dystrophy: A Bioinformatics Approach.

Journal: Cornea

Published: June 26, 2025

Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomised phase IIa clinical trial (RCT).

Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomised phase IIa clinical trial (RCT).

Journal: EClinicalMedicine

Published: May 05, 2025

Showing 1-12 of 276

Last Updated: 09/26/2026